The effect and mechanism of combined exposure of MC-LR and NaNO2 on liver lipid metabolism

Microcystin-LR (MC-LR) and sodium nitrite (NaNO₂) co-exist in the environment and are hepatotoxic. The liver has the function of lipid metabolism, but the impacts and mechanisms of MC-LR and NaNO₂ on liver lipid metabolism are unclear. Therefore, we established a chronic exposure model of Balb/c mice and used LO2 cells for in vitro verification to investigate the effects and mechanisms of liver lipid metabolism caused by MC-LR and NaNO₂. The results showed that after 6 months of exposure to MC-LR and NaNO₂, the lipid droplets content was increased, and the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were raised in the liver (P < 0.05). Moreover, MC-LR and NaNO₂ synergistically induced hepatic oxidative stress by decreasing total superoxide dismutase (T-SOD) activity and glutathione (GSH) levels and increasing malondialdehyde (MDA) content levels. In addition, the levels of Nrf2, HO-1, NQO1 and P-AMPK was decreased and Keap1 was increased in the Nrf2/HO-1 pathway. The key factors of lipid metabolism, SREBP-1c, FASN and ACC, were up-regulated in the liver. More importantly, there was a combined effect on lipid deposition of MC-LR and NaNO₂ co-exposure. In vitro experiments, MC-LR and NaNO₂-induced lipid deposition and changes in lipid metabolism-related changes were mitigated after activation of the Nrf2/HO-1 signaling pathway by the Nrf2 activator tertiary butylhydroquinone (TBHQ). Additionally, TBHQ alleviated the rise of Reactive Oxygen Species (ROS) in LO2 cells induced by MC-LR and NaNO₂. Overall, our findings indicated that MC-LR and NaNO₂ can cause abnormal liver lipid metabolism, and the combined effects were observed after MC-LR and NaNO₂ co-exposure. The Nrf2/HO-1 signal pathway may be a potential target for prevention and control of liver toxicity caused by MC-LR and NaNO₂.

Hepatotoxicity; Lipid metabolism; Microcystin-LR; NaNO(2); Nrf2/HO-1 pathway.